In this session, we will provide a brief overview of the evolving ICH E20 effort with the goal to provide a transparent and harmonized set of principles for the design, conduct, analysis, and interpretation of adaptive clinical trials.
Learning Objectives
Considerations specific to adaptive design using Bayesian methods will be discussed. Opportunities and challenges of using Bayesian methods in the regulatory setting will also be highlighted.
